Contrast Media/Contrast Agents Market

Introduction

Contrast media and agent market have significantly evolved over the past century. Initially, Iodine and Barium-based agents were used by radiologists and practitioners, now gold nanoparticle and radio pharmaceuticals are used. Advanced techniques such as gas micro bubble technology in gas and MRI imaging technology will prove as an essentials drivers in the wide use contrast agents.

Global contrast agent and media market is fairly mature at current stage and still have the potential to groom in coming years. Some factors supporting to the growth of this market are diagnostic imaging, image guided surgical procedures, increasing rates of cardiac and cancer disorders and advancements in diagnostic technology. U.S. is currently holding the maximum shares of this market, followed by Japan and Europe.

Increasing demand for image guided procedures and diagnostics, increasing incidence and mortality of cardiac and Cancer diseases, technology advancements in medical imaging market are some of the major driving forces resulting into the growth of the market.

With these economies undergoing medical reforms affecting the sales of contrast agents and economic slowdowns are some factors restraining the growth of the market. Growing investments in immature markets and advanced contrast reagents having properties of contrast media and radio pharmaceuticals are some opportunities in contrast agent market.

Market Segmentation

basis of product type	Barium-based contrast media Iodinated contrast media  Gadolinium-based contrast media
basis of route of administration	oral injectable rectal  ureteral
basis of medical procedure	X-ray computed tomography magnetic resonance imaging ultrasound  Catheterization laboratory
indication based	cardiovascular disorders Respiratory diseases gastrointestinal disorders  nepoherological disorders
basis of application	radiology interventional radiology interventional cardiology
basis of geography	North America Europe APAC RoW

Amag pharmaceuticals, Inc., Bayer healthcare pharmaceuticals, Bracco Imaging Spa, Covidien, Cmc Contrast AB, Daiichi Sankyo Co., Ltd., GE Healthcare, Genovis AB, Guerbet Group,Lantheus Medical Imaging, Inc., Nanopet Pharma GmbH., Nanoscan Imaging, LLC.,Sanochemia Pharmazeutika AG, Spago Imaging AB, Subhra Pharma Private, Ltd. and Taejoon Pharm Co., Ltd., are some of the key players in contrast media and agents market.